Tag: Zydus Cadila

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico

by  • 

Zydus Cadila, announced that it has received approval from the Mexican regulatory authority COFEPRIS to conduct clinical trials with its biological therapy, Pegylated Interferon alpha-2b, ‘PegiHepTM’ This will be an open-label, randomized, comparator controlled study of Pegylated IFN alfa-2b to evaluate safety, efficacy and tolerability in patients with COVID-19.  According to the Company’s press statement,…

read more..

Zydus enters licensing agreement with Gilead for manufacturing of Remdesivir

by  • 

Zydus Cadila, an innovation-driven global healthcare company, announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc., for the manufacturing and distribution of Remdesivir, the investigational drug, which has been issued an Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) to treat patients suffering from severe symptoms of Novel…

read more..